Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Silk Road Medical Enters Definitive Deal To Be Acquired By Boston Scientific For $27.50 In Cash Per Share, Representing An Equity Value Of Approximately $1.26B

Author: Benzinga Newsdesk | June 18, 2024 06:01am

The per share price represents an approximate 38% premium to the volume-weighted average share price of Silk Road Medical's common stock over the past 60 days.

Upon the completion of the transaction, Silk Road will become a wholly-owned subsidiary of Boston Scientific.

Posted In: BSX SILK


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist